Journal
JOURNAL OF ETHNOPHARMACOLOGY
Volume 150, Issue 2, Pages 568-575Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.jep.2013.09.009
Keywords
Hepatitis B virus; DHBV; Hydrocotyle sibthor-pioides; Asiaticoside
Categories
Funding
- National Natural Science Foundation of China [81260674, 81260505]
- Foundation of Guangxi Key laboratory for the Prevention & Treatment of Regional High-Incidence Diseases [KFJJ2010-71, KFJJ2011-37]
- Guangxi Scientific Research & Technology Development Research Project [10124008-6, 0992003A-2]
- Guangxi Science and Technology Foundation Platform Construction Project [12-97-20]
Ask authors/readers for more resources
Ethnopharmacological relevance: Hydrocotyle sibthotpioides (Apiaceae) have been used as a folk remedy for the treatment of fever, edema, detoxication, throat pain, psoriasis and hepatitis B virus infections in China. The aim of this study is to isolate and identify an anti-HBV compound from this herb. Materials and methods: A compound (saponin) was isolated from the active ethanol extract using bioassay-guided screening. The structure of the saponin was elucidated by spectroscopic methods and compared with published data. The anti-HBV activity of the saponin was evaluated by detecting the levels of HBV antigens, extracellular HBV DNA, nuclear covalent closed circular DNA (cccDNA) and five HBV promoters in HepG2.2.15 cells. In addition, the levels of serum HBsAg/HBeAg, DHBV DNA, ALT/AST and hepatic pathological changes were analyzed in DHBV-infected ducks. Results: The chemical analysis indicated that the saponin isolated from Hydrocotyle sibthomioides is asiaticoside. The pharmacodynamics experimental studies showed that asiaticoside effectively suppressed the levels of HBsAg/HBeAg, extracellular HBV DNA and intracellular cccDNA in a dose-dependent manner. Furthermore, experiments demonstrated that asiaticoside markedly reduced viral DNA transcription and replication by inhibiting the activities of core, s1, s2, and X gene promoters. In addition, asiaticoside markedly reduced DHBV replication without any obvious signs of toxicity. The levels of serum DHBV DNA, HBsAg/HBeAg were increased 3 days after drug withdrawal, but the levels rebounded slightly in the asiaticoside treatment groups compared with the 3TC treatment group. Moreover, analysis of the serum ALT/AST levels and the liver pathological changes indicated that asiaticoside could alleviate liver damage. Conclusions: Our results show that asiaticoside could efficiently inhibit HBV replication both in vitro and in vivo, and asiaticoside may be a major bioactive ingredient in Hydrocotyle sibtholpioides. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available